Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma
K
Kevin Card
(Retina and Macular Disease Service New England Eye Center Boston Massachusetts USA)
R
Rizwan Haq
(Department of Hematology and Oncology Dana Farber Cancer Institute Boston Boston Massachusetts USA)
J
John Mignano
(Department of Radiation Oncology Tufts University Medical Center Boston Massachusetts USA)
S
Shilpa J. Desai
(Retina and Macular Disease Service New England Eye Center Boston Massachusetts USA)
Article Details
Volume / Issue
Vol. 76, Issue 3
Published
May 01, 2026
ISSN
0007-9235
Publisher
Wiley
Authors (4)
K
Kevin Card
Retina and Macular Disease Service New England Eye Center Boston Massachusetts USA
R
Rizwan Haq
Department of Hematology and Oncology Dana Farber Cancer Institute Boston Boston Massachusetts USA
J
John Mignano
Department of Radiation Oncology Tufts University Medical Center Boston Massachusetts USA
S
Shilpa J. Desai
Retina and Macular Disease Service New England Eye Center Boston Massachusetts USA
Related Articles from this Journal
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
Xia Wu, Heather Landau et al.
May 2026
10.3322/caac.70092
Screening for colorectal cancer
May 2026
10.3322/caac.70087
Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”
May 2026
10.3322/caac.70093
Blood tests for colorectal cancer—Hype ahead of evidence?
Gloria D. Coronado, David A. Lieberman
May 2026
10.3322/caac.70088
Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making
Lucas Kallas‐Silva, Victor Alexandre dos Santos Valsecchi et al.
May 2026
10.3322/caac.70086